Tag:
Affimed Therapeutics
Latest Headlines
Latest Headlines
Affimed raises €20M to fund innovative antibody trials
With its lead antibody program poised to go into the clinic later this year and two more therapies expected to follow in 2011, Germany's Affimed Therapeutics AG has raised 20 million euros in a
Affimed spins out discovery ops, focuses on lymphoma drug
Germany's Affimed Therapeutics has spun out its antibody discovery activities to form a new company. AbCheck, to be based in the Czech Republic, will continue Affimed's current discovery work and
